Enabling SARS-CoV-2 Wastewater Surveillance Using an Integrated Microfluidic Chip
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c00831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Mohammad Dehghan Banadaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical and Aerospace Engineering, College of Engineering, University of Kentucky, Lexington, KY 40506, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, Wastewater, COVID-19, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute of Environmental Health Sciences, Directorate for Biological Sciences.
Abstract (Originalsprache)
Wastewater-based epidemiology (WBE) has emerged as a critical public health tool, offering cost-effective and noninvasive surveillance of infectious diseases through wastewater testing. Despite its potential, WBE implementation in low-resource settings is hindered by infrastructure limitations, lack of technical expertise, and dependence on centralized laboratories. This study presents a novel concentration-extraction-identification device (CEID), a point-of-use platform that integrates nucleic acid concentration, extraction, and detection into an affordable and user-friendly chip. The CEID employs immiscible filtration assisted by surface tension (IFAST) for nucleic acid extraction and colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) for pathogen detection. Key parameters of the CEID were characterized and optimized, resulting in efficient nucleic acid extraction with minimal carry-over of inhibitory molecules. The performance was validated using SARS-CoV-2 spiked wastewater samples, achieving a detection limit of 113 Cp/mL. The CEID was further validated through a 6-week surveillance study, successfully detecting SARS-CoV-2 in wastewater from two locations with a high correlation to standard WBE methods and RT-qPCR. Costing approximately $11 per sample and requiring minimal hands-on time, the CEID demonstrates significant advantages in affordability, simplicity, and adaptability for rural and underserved regions. This technology offers a scalable solution to democratize WBE, enhancing global infectious disease surveillance and response, particularly in low- and middle-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Mechanical and Aerospace Engineering, College of Engineering, University of Kentucky, Lexington, KY 40506, United States.
- Department of Biomedical Engineering, College of Engineering, University of Kentucky, Lexington, KY 40506, United States.
- WWAMI School of Medicine, University of Alaska Anchorage, Anchorage, AK 99508, United States.
ORCID-Profile: Mohammad Dehghan Banadaki, Soroosh Torabi
Förderung
- NIDA NIH HHS
- National Institute of Environmental Health Sciences
- Directorate for Biological Sciences
- Centers for Disease Control and Prevention
- National Institute on Drug Abuse
- National Science Foundation
Zitieren
APA
Dehghan Banadaki, M., Torabi, S., Strike, W. D., Phillips, A. R., Sakhaei, A., Farahbakhsh, S., Noble, A., Keck, J. W., & Berry, S. M. (2025). Enabling SARS-CoV-2 Wastewater Surveillance Using an Integrated Microfluidic Chip. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c00831
Vancouver
Dehghan Banadaki M, Torabi S, Strike WD, Phillips AR, Sakhaei A, Farahbakhsh S, et al. Enabling SARS-CoV-2 Wastewater Surveillance Using an Integrated Microfluidic Chip. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c00831
BibTeX
@article{DehghanBanadaki2025,
author = {Dehghan Banadaki, Mohammad and Torabi, Soroosh and Strike, William D and Phillips, Abigail R and Sakhaei, Amirmohammad and Farahbakhsh, Soroush and Noble, Ann and Keck, James W and Berry, Scott M},
title = {Enabling SARS-CoV-2 Wastewater Surveillance Using an Integrated Microfluidic Chip},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c00831}
}
EUVIMED